
Ubu buryo bwuzuye buragufasha kumva amahitamo yawe kuvura icyiciro cya 3 kitari gito kanseri y'ibihaha ivura hafi yanjye. Tuzashakisha uburyo butandukanye bwo kuvura, ibitekerezo byo guhitamo ubuvuzi bukwiye, hamwe nibikoresho byo gufasha urugendo rwawe. Kuyobora isuzuma nkibi birashobora kuba byinshi, ariko ibyemezo byamenyeshejwe nibyingenzi. Aka gatabo gatanga amakuru ukeneye kugirango utangire iyo nzira.
Kanseri y'ibihaha itari ntoya (NSCLC) ni yo isuzuma kanseri y'ibihaha. Icyiciro cya 3 NSCLC yerekana ko kanseri yakwirakwiriye hakurya y'ibihaha igera kuri lymph node cyangwa izindi ngingo. Bikora neza kuvura icyiciro cya 3 kitari gito kanseri y'ibihaha ivura hafi yanjye bisaba uburyo bwihariye bushingiye kubintu nkubwoko bwihariye na kanseri ya kanseri, ubuzima bwawe muri rusange, hamwe nibyo ukunda.
Icyiciro cya 3 NSCLC yongeye gushyirwa mubyiciro IIIA na Stage IIIB, bitewe nurwego rwakwirakwijwe. Gutegura neza ni ngombwa muguhitamo inzira nziza ya kuvura icyiciro cya 3 kitari gito kanseri y'ibihaha ivura hafi yanjye. Oncologue wawe azagusobanurira icyiciro cyawe ningaruka zacyo.
Uburyo bwinshi bwo kuvura bushobora gusabwa icyiciro cya 3 NSCLC, gikunze gukoreshwa hamwe. Muri byo harimo:
Rimwe na rimwe, kubaga birashobora kuba uburyo bwo gukuraho ikibyimba hamwe na lymph node hafi. Ibishoboka byo kubagwa biterwa nubunini n’aho ikibyimba giherereye, hamwe nubuzima bwawe muri rusange.
Chimoterapi ikoresha imiti yica kanseri. Irashobora gutangwa mbere yo kubagwa (neoadjuvant chemotherapie) kugirango igabanye ikibyimba, nyuma yo kubagwa (chimiotherapie adjuvant) kugirango igabanye ibyago byo kongera kubaho, cyangwa nkubuvuzi bwibanze niba kubagwa bidashoboka.
Imiti ivura imirasire ikoresha imirasire yingufu nyinshi kugirango yibasire kanseri. Irashobora gukoreshwa wenyine cyangwa ifatanije na chimiotherapie cyangwa kubaga. Imiti ivura imirasire yo hanze irasanzwe cyane, ariko brachytherapy (imirasire yimbere) nayo irashobora gutekerezwa.
Ubuvuzi bugamije gukoresha imiti yibasira kanseri ya kanseri, bigatuma ingirabuzimafatizo zifite ubuzima bwiza. Imikorere yubuvuzi bugamije guterwa nubwoko bwimiterere ihindagurika yibibyimba byawe. Oncologue wawe azakora ibizamini kugirango umenye niba uri umukandida.
Immunotherapy ikoresha imbaraga z'umubiri wawe zo kurwanya kanseri. Immune igenzura ibuza ni ubwoko bwikingira rishobora kuba ingirakamaro cyane kubarwayi ba NSCLC.
Guhitamo ikigo cyita kuri kanseri nicyemezo gikomeye. Suzuma ibintu bikurikira:
Kubuvuzi bwiza bwa kanseri, tekereza kubushakashatsi nka Shandong Baofa Ikigo Cyubushakashatsi Kanseri. Batanga ibikoresho bigezweho hamwe nitsinda ryinzobere mu bumenyi bwa oncologue baharanira gutanga kanseri yuzuye.
Urugendo rwo kuvura kanseri rushobora kuba ingorabahizi, haba kumubiri no mumarangamutima. Wibuke gukoresha sisitemu yo gushyigikira iboneka, harimo:
Kubona uburenganzira kuvura icyiciro cya 3 kitari gito kanseri y'ibihaha ivura hafi yanjye bisaba gutekereza neza no gufatanya nitsinda ryanyu ryita kubuzima. Aka gatabo gatanga intangiriro, ariko ubuyobozi bwihariye buva kuburambe bwa oncologiste ni ngombwa.
Aya makuru agenewe intego zuburezi gusa kandi ntizigomba gufatwa nkinama zubuvuzi. Buri gihe ujye ubaza umuganga wawe cyangwa undi muntu winzobere mubuzima wujuje ibisabwa kugirango asuzume kandi avure indwara iyo ari yo yose.